GB Sciences, Inc. (GBLX)
Develops cannabis-based prescription medicines for neurological and pain conditions
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+50.0%
The outlook
GBLX is trading near its 52-week low with a bearish analyst sentiment overall. The stock sits well below both its 50- and 200-day moving averages, reflecting a downward price trend. Current market data shows minimal activity and historically weak positioning within its recent range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$122,121
52-wk high
$0.50
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—